Tyra Biosciences, Inc. Share Price Today, Financials & AI Analysis — Stockinder

Jarvis is thinking

Tyra Biosciences, Inc. Share Price Today, Financials & AI Analysis — Stockinder

Income Statement

	2025-12-31	2024-12-31	2021-12-31
Profit from core operations after subtracting the cost of revenue and operating expenses like R&D and marketing, but before interest and taxes.	-$132.76M	-$104.18M	-$26.29M
The company's bottom-line profit after all expenses, interest, and taxes are subtracted.	-$119.95M	-$86.48M	-$26.29M
Net income divided by the number of shares outstanding — profit attributable to each share.	$-2.01	$-1.51	$-1.91
Like basic EPS, but accounts for shares that could be created from stock options or convertible securities — a more conservative per-share profit figure.	$-2.01	$-1.51	–

Balance Sheet

	2025-12-31	2024-12-31	2021-12-31
Cash and highly liquid short-term investments the company can access almost immediately.	$77.39M	$91.97M	$302.20M
Everything the company owns that has value — cash, property, inventory, investments, and more.	$282.61M	$363.56M	$306.70M
Everything the company owes — debt, unpaid bills, and other obligations.	$23.43M	$20.41M	$4.96M
What would be left for shareholders if the company sold all its assets and paid off all its debts — total assets minus total liabilities.	$259.18M	$343.15M	$301.74M

Cash Flow Statement

	2025-12-31	2024-12-31	2021-12-31
Actual cash generated by the core business, as opposed to accounting profit, which can include non-cash items.	-$95.14M	-$69.77M	-$23.75M
Cash spent on physical assets like property, equipment, and infrastructure to maintain or grow the business.	$141000	$664000	$661000
Cash left over after capital expenditures — money the company could use for dividends, buybacks, debt repayment, or reinvestment.	-$95.28M	-$70.44M	-$24.41M